InsidersTradesSigma
Follow the Acasti Pharma Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 27 September 2023 (Acquisition). Among the most active insiders: Kavuru Vimal. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Acasti Pharma Inc. 是一家生物制药公司，专注于开发心血管疾病治疗方法。该公司在纳斯达克上市，股票代码为 ACST。